期刊文献+

立体定向放射治疗胸腺瘤17例 被引量:3

下载PDF
导出
摘要 目的:探讨立体定向放射治疗胸腺瘤的近期疗效。方法:17例胸腺瘤接受立体定向放射治疗(全身伽玛刀),60%-80%等剂量曲线包绕临床靶区(CTV),处方剂量每次4—7Gy,隔日或每日治疗,共6-10次,总剂量45-48Gy,2周内完成。蛄栗:17例均获随访,6个月、12个月、24个月其有效率(CR+PR)分别为88.2%、82.4%、70.6%。无放射性肺炎、食管炎、脊髓炎并发症发生。结论:对非手术或不能手术的胸腺瘤,尤其是老年患者采用立体定向放射治疗安全、有效,近期疗效好,副作用小。
出处 《蚌埠医学院学报》 CAS 2007年第1期95-96,共2页 Journal of Bengbu Medical College
  • 相关文献

参考文献4

二级参考文献13

  • 1汪楣,杨宗贻,苗延浚,殷蔚伯,谷铣之.胸腺瘤105例临床分析[J].中华放射肿瘤学杂志,1991,0(1):16-20. 被引量:12
  • 2刘英.胸腺瘤放射治疗的临床意义——附107例报告[J].肿瘤防治研究,1985,12(4):174-176.
  • 3Walher JC, Housset J, Remonier HB,et al. The role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol, 1998,6( 11 ) : 1722-1726.
  • 4汪楣 赵森 见:谷铣之 殷蔚伯 刘泰福 等主编.纵隔肿瘤[A].见:谷铣之,殷蔚伯,刘泰福,等主编.肿瘤放射治疗学[C].北京:北京医科大学中国协和医科大学联合出版社,1993.527-538.
  • 5Maggi G, casadio C, Cavallo A, et al. Thymoma : results of 241 operated cases. Ann Thorac Surg,1991,51:152-156.
  • 6Wilkins EW,Grillo HC,Moncure AC,et al. Maxwell Chamber lain Memorial paper. Role of staging in prognosis and management of thymoma. Ann Thorac Surg, 1991,51 :888-892.
  • 7Nakahara K, Ohno K, Hashimoto J, et al. Thymoma : results with complete ressection and adjuvant postoperative irradiation in 141 consecutive patients. J Thorac Cardiovas Surg,1988,95 : 1041-1047.
  • 8Ichinose Y, Ohta M, Yano T, et al. Treatment of invasive thymoma with pleural dissemination. J Surg Oncol, 1993,54 : 180-183.
  • 9Suit HD. Local control and Patient survival. Int Radiat Oncol Biol Phys, 1992,23:630-660.
  • 10胡逸民 见:胡逸民 杨定宇主编.适形放射治疗[A].见:胡逸民,杨定宇主编.肿瘤放射治疗技术[C].北京:北京医科大学中国协和医科大学联合出版社,1999.98,102.

共引文献11

同被引文献47

  • 1姬巍,冯勤富,周宗玫,汪楣,陈东福,张宏兴,肖泽芬,王绿化,殷蔚伯.73例胸腺癌的治疗与预后分析[J].中华放射肿瘤学杂志,2006,15(2):97-100. 被引量:8
  • 2Detterbeck F, Youssef S, Ruffini E, et al. A review of prognostic factors in thymic malignancies [ J ]. J Thorac Oncol, 2011,6 (7) : 1698 - 1704.
  • 3爱德华·海普林,卡洛斯·佩雷兹,路德·布莱德.放射肿瘤学原理和实践(下卷)[M].天津:天津科技翻译出版社,2012:1224-1228.
  • 4NCCN. The NCCN thymoma and thymic carcinomas clinical prac- tice guidelines in oncology ( version 11 2015 ) [ EB/OL ]. http :// www. nccn. org/professionals/physician _ gls/f_ guidelines, asp # site,2015 - 3 - 20.
  • 5Detterbeck FC, Nicholson AG, Kondo K,et al. The Masaoka-Koga stage classification for thymic malignancies:clarification and defi- nition of terms[J]. J Thorac Oncol,2011,6(7) : 1710 - 1716.
  • 6Gao L, Wang C, Fang W, et al. Outcome of multimodality treatment for 188 cases of type B3 thymoma[J]. J Thorac Oncol,2013,8 (10) :1329 - 1334.
  • 7Marx A, Strbel P, Badve SS, et al. ITMIG consensus statement on the use of the WHO histological classification of thymoma and thy- mic carcinoma : refined definitions, histological criteria, and repor- ting[ J]. J Thorac Ouco1,2014,9(5 ) :596 -611.
  • 8Guerrera F, Rendina EA, Venuta F, et al. Does the World Health Organization histological classification predict outcomes after thy- momectomy results of a multicentre study on 750 patients[ J]. Eur J Cardiothorae Surg,2014, doi : 10. 1093/ejcts/ezu368.
  • 9Onuki T, Ishikawa S, Yamamoto T, et al. Pathologic radioresponse of preoperatively irradiated invasive thymomas [ J ]. J Thorac On- eo1,2008,3 ( 3 ) :270 - 276.
  • 10Bretti S, Berruti A, Loddo C, et al. Multimodal management of sta- ges III - IVa malignant thymoma [ J ]. Lung Cancer, 2004,44 (1) :69 -77.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部